Stockreport

Mild Cognitive Impairment Pipeline Guide, H1 2020 - Therapeutics Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
PDF DUBLIN, April 22, 2020 /PRNewswire/ -- The "Mild Cognitive Impairment - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.This [Read more]